Biomarkers in Neuropsychiatry · 2023 · 53 citations · 89 references
Life SciencesNeurologyNeuroscienceDementiaNeurodegenerationNeuropsychiatryCerebrospinal Fluid BiomarkersDementia With Lewy BodiesNeurodegenerative DiseasesNeurodegenerative DisordersParkinson DiseaseParkinsonian DisordersAlpha-synuclein BiomarkersBiomarkers Of Parkinsonian DisordersClinical Diagnosis Of ParkinsonismClinical Value AssessmentDisease BiomarkersNeurological Disease BiomarkersParkinson Disease BiomarkersParkinson Disease Imaging
Biomarkers in Parkinson’s disease are widely researched in the field of neuropsychiatry. Though Parkinson’s disease is diagnosed clinically, biomarkers prove to be a promising means to identify disease in early stages, track disease progression, and distinguish Parkinson’s disease from other conditions like dementia with Lewy bodies. There is debate on the level of clinical utility specific Parkinson’s disease biomarkers have. This state of the art review discusses recent advances in the search for Parkinson’s disease biomarkers and delves into the clinical value of each, exploring biomarkers obtained through different modalities like cerebrospinal fluid, serum, genetics and imaging.
89
Staging of brain pathology related to sporadic Parkinson’s disease
Heiko Braak, Kelly Del Tredici, Udo Rüb et al. · Neurobiology of Aging · 2002 · 10.8K citations
Medicine, Neurology, Neuroscience +13
Mutation in the α-Synuclein Gene Identified in Families with Parkinson's Disease
Mihael H. Polymeropoulos, Christian Lavedan, Elisabeth Leroy et al. · Science · 1997 · 8.2K citations
Mutations in LRRK2 Cause Autosomal-Dominant Parkinsonism with Pleomorphic Pathology
Alexander Zimprich, Saskia Biskup, Petra Leitner et al. · Neuron · 2004 · 3.1K citations · Full text